Therapeutic Areas
Advancing Oncology Research
We have a long and proven track record in the development of small molecules for oncology. We help our partners advance cancer programs from discovery through target identification/validation, hit identification/characterization, lead generation/optimization, IND filing and then NDA filing.
Axcelead focuses on biology and following the data.
We harness our wealth of expertise in target identification/validations, in vitro cell based assays, in vivo studies and translational research to achieve compounds with optimal profiles to perform well in the preclinical, clinical and real-world settings.
And given our success in this area, we are leveraging these learnings and expanding into immuno-oncology to create drugs that affect the cancer tumor microenvironment and host immunity.
Oncology Brochure
